Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Mind Cure Health Inc (MCURF)

Mind Cure Health Inc (MCURF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade MCURF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2994 +6.58%
on 08/02/21
0.3871 -17.57%
on 07/15/21
-0.0444 (-12.21%)
since 07/02/21
3-Month
0.2535 +25.88%
on 05/18/21
0.4000 -20.23%
on 06/28/21
-0.0156 (-4.66%)
since 05/03/21

Most Recent Stories

More News
MINDCURE Launches Second Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical Research

COMTEX_390490679/2669/2021-07-27T03:30:28

MCUR.CN : 0.405 (-2.41%)
MCURF : 0.3191 (-8.17%)
MINDCURE Announces Filing of U.S. Provisional Patent Applications for Company's First Fully Synthetic Routes to Create an Ibogaine Psychedelic Compound

COMTEX_389720635/2669/2021-07-13T03:30:29

MCUR.CN : 0.405 (-2.41%)
MCURF : 0.3191 (-8.17%)
MINDCURE Adopts Advance Notice Policy

/PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("" or the "Company"), a leader in advanced proprietary technology and research for psychedelics, is pleased to announce that...

MCUR.CN : 0.405 (-2.41%)
MCURF : 0.3191 (-8.17%)
Maxim Group Initiates Coverage of Mind Cure Health

COMTEX_389138717/2669/2021-06-30T03:30:30

MCUR.CN : 0.405 (-2.41%)
MCURF : 0.3191 (-8.17%)
MINDCURE Develops Proprietary Ketamine-Enhanced Psychotherapy Protocols for Treatment of Pain and Depression

COMTEX_388414578/2669/2021-06-17T03:30:28

MCUR.CN : 0.405 (-2.41%)
MCURF : 0.3191 (-8.17%)
MINDCURE Successfully Completes First Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical Research

COMTEX_387786784/2669/2021-06-03T10:04:31

MCUR.CN : 0.405 (-2.41%)
MCURF : 0.3191 (-8.17%)
This is Why Psilocybin May be Able to Help Millions with Mental Health Issue

Psychedelics could offer help for millions suffering from depression. In fact, according to the Washington ...

FTRPF : 5.7460 (-2.32%)
WESA.CN : 3.130 (+4.33%)
DBDID : 2.2000 (-4.76%)
RVV.CN : 0.500 (+2.04%)
RVVTF : 0.4000 (-1.72%)
MCUR.CN : 0.405 (-2.41%)
MCURF : 0.3191 (-8.17%)
FTRP.CN : 5.550 (+1.46%)
MYND.CN : 0.750 (+7.14%)
Dr. Joel Raskin, a leader in psychiatry and neuroscience drug development, joins MINDCURE as Chief Medical Officer

COMTEX_386934898/2669/2021-05-20T03:30:28

LLY : 255.99 (+3.81%)
MCUR.CN : 0.405 (-2.41%)
MCURF : 0.3191 (-8.17%)
MINDCURE Appoints Dr. John Brownstein, the Chief Innovation Officer at Boston Children's Hospital, as Company Advisor

COMTEX_386870536/2669/2021-05-19T03:30:29

MCUR.CN : 0.405 (-2.41%)
MCURF : 0.3191 (-8.17%)
MINDCURE Shares Update on Strong Financial Position, Near Term Revenue Drivers and Timeline for iSTRYM's Market Launch, Delivering Mental Wealth

MINDCURE Shares Update on Strong Financial Position, Near Term Revenue Drivers and Timeline for iSTRYM's Market Launch, Delivering Mental Wealth

LCDX : 0.3325 (-2.21%)
MCUR.CN : 0.405 (-2.41%)
MCURF : 0.3191 (-8.17%)

Key Turning Points

3rd Resistance Point 0.3613
2nd Resistance Point 0.3504
1st Resistance Point 0.3348
Last Price 0.3191
1st Support Level 0.3083
2nd Support Level 0.2974
3rd Support Level 0.2818

See More

52-Week High 0.8584
Fibonacci 61.8% 0.6273
Fibonacci 50% 0.5559
Fibonacci 38.2% 0.4846
Last Price 0.3191
52-Week Low 0.2535

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar